These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results
1. ZBH reported Q1 adjusted EPS of $1.81, beating estimates of $1.77. 2. Sales reached $1.91 billion, slightly above the consensus of $1.9 billion. 3. Fiscal year 2025 EPS forecast lowered to $7.90-$8.10 from $8.15-$8.35. 4. Analysts adjusted price targets downward for ZBH post-earnings announcement. 5. Shares increased by 0.7% to $91.08 following earnings release.